Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Freedom Bunker
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

OpenAI Reportedly Targets $1 Trillion Valuation As IPO Window Opens In 2027

% of readers think this story is Fact. Add your two cents.


OpenAI Reportedly Targets $1 Trillion Valuation As IPO Window Opens In 2027

Earlier this week, OpenAI CEO Sam Altman addressed the topic of taking the chatbot maker public during a livestream. He said that while there are no concrete plans or set timeline, “it’s fair to say an IPO is the most likely path for us.“ 

After Altman’s comments, Reuters reported, citing three people familiar with the matter, that OpenAI is indeed preparing for an IPO, with a securities filing expected in late 2026 and a market debut in 2027 at a potential valuation of $1 trillion

Here’s more from the report:

OpenAI is considering filing with securities regulators as soon as the second half of 2026, some of the people said. In preliminary discussions, the company has looked at raising $60 billion at the low end and likely more, the people said. They cautioned that talks are early and plans – including the figures and timing – could change depending on business growth and market conditions.

Chief Financial Officer Sarah Friar has told some associates the company is aiming for a 2027 listing, the people said. But some advisers predict it could come even sooner, around late 2026.

While an OpenAI spokesperson maintains that “an IPO is not our focus,” this week’s restructuring news, which reduced the company’s dependence on Microsoft and shifted governance under the OpenAI Foundation, only suggests preparation for public markets, as it paves the way for OpenAI to use public stock for large-scale acquisitions and capital-intensive infrastructure projects to support Altman’s plan to invest trillions in AI development.

OpenAI has an annualized revenue run rate of approximately $20 billion, though losses are mounting. There was a report at the start of the week that said the Microsoft CFO internally warned about Altman’s data center spending, which could unleash data center overcapacity.

Related: 

OpenAI was most recently valued at $500 billion, with major investors including Microsoft (27% stake), SoftBank, Thrive Capital, and Abu Dhabi’s MGX.

However, the potential IPO window for OpenAI comes at a time when Goldman analysts forecast data center peak occupancy will begin to weaken (read here), an indication that more supply will come online amid the massive wave of data center buildouts expected next year (read here).

Tyler Durden Thu, 10/30/2025 – 11:25


Source: https://freedombunker.com/2025/10/30/openai-reportedly-targets-1-trillion-valuation-as-ipo-window-opens-in-2027/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login